APO Research
Talk to an analyst

APO RESEARCH · REPORT

Mood Stabilizers

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Mood Stabilizers Market Outlook and Growth Opportunities 2026

22 December 2025198 pages

Choose your research edition.

Industry ResearchMood Stabilizers Industry Research Report 2026106 pages · $2,950 USDIndustry Growth & TrendsGlobal Mood Stabilizers Industry Growth and Trends Forecast to 203278 pages · $3,450 USDMarket StructureGlobal Mood Stabilizers Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032178 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Mood Stabilizers Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Mood Stabilizers Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Mood Stabilizers market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Mood Stabilizers is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Mood Stabilizers is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Mood Stabilizers is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Mood Stabilizers market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Mood Stabilizers market include Pfizer, GlaxoSmithKline, Otsuka Pharmaceutical and Bristol-Myers Squibb, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Mood Stabilizers market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Mood Stabilizers and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Mood Stabilizers sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Mood Stabilizers market size, projected growth trends, production technologies, key applications, and end-use industries.

Mood Stabilizers Segment by Company

Pfizer

GlaxoSmithKline

Otsuka Pharmaceutical

Bristol-Myers Squibb

Mood Stabilizers Segment by Type

Asenapine

Valproate

Carbamazepine

Lamotrigine

Mood Stabilizers Segment by Application

Hospital Pharmacies

Drug Stores

Others

Mood Stabilizers Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Mood Stabilizers status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Mood Stabilizers market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Mood Stabilizers significant trends, drivers, influence factors in global and regions.

6. To analyze Mood Stabilizers competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mood Stabilizers market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Mood Stabilizers and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mood Stabilizers.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Mood Stabilizers market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Mood Stabilizers industry.

Chapter 3: Detailed analysis of Mood Stabilizers manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Mood Stabilizers in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Mood Stabilizers in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Mood Stabilizers Industry Trends Table 2. Mood Stabilizers Industry Drivers Table 3. Mood Stabilizers Industry Opportunities and Challenges Table 4. Mood Stabilizers Industry Restraints Table 5. Global Mood Stabilizers Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Mood Stabilizers Revenue Share by Company (2021-2026) Table 7. Global Mood Stabilizers Sales Volume by Company (k units) & (2021-2026) Table 8. Global Mood Stabilizers Sales Volume Share by Company (2021-2026) Table 9. Global Mood Stabilizers Average Price (US$/unit) of Company (2021-2026) Table 10. Global Mood Stabilizers Company Ranking, (2024-2026) & (USD Million) Table 11. Global Mood Stabilizers Key Company Manufacturing Base & Headquarters Table 12. Global Mood Stabilizers Company, Product Type & Application Table 13. Global Mood Stabilizers Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Mood Stabilizers by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Asenapine Table 18. Significant Companies of Valproate Table 19. Significant Companies of Carbamazepine Table 20. Significant Companies of Lamotrigine Table 21. Global Mood Stabilizers Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 22. Global Mood Stabilizers Sales Volume by Type (2021-2026) & (k units) Table 23. Global Mood Stabilizers Sales Volume by Type (2027-2032) & (k units) Table 24. Global Mood Stabilizers Sales Volume Share by Type (2021-2026) Table 25. Global Mood Stabilizers Sales Volume Share by Type (2027-2032) Table 26. Global Mood Stabilizers Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Mood Stabilizers Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Mood Stabilizers Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Mood Stabilizers Sales Value Share by Type (2021-2026) Table 30. Global Mood Stabilizers Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Hospital Pharmacies Table 32. Significant Companies of Drug Stores Table 33. Significant Companies of Others Table 34. Global Mood Stabilizers Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 35. Global Mood Stabilizers Sales Volume by Application (2021-2026) & (k units) Table 36. Global Mood Stabilizers Sales Volume by Application (2027-2032) & (k units) Table 37. Global Mood Stabilizers Sales Volume Share by Application (2021-2026) Table 38. Global Mood Stabilizers Sales Volume Share by Application (2027-2032) Table 39. Global Mood Stabilizers Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Mood Stabilizers Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Mood Stabilizers Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Mood Stabilizers Sales Value Share by Application (2021-2026) Table 43. Global Mood Stabilizers Sales Value Share by Application (2027-2032) Table 44. Global Mood Stabilizers Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 45. Global Mood Stabilizers Sales by Region (2021-2026) & (k units) Table 46. Global Mood Stabilizers Sales Market Share by Region (2021-2026) Table 47. Global Mood Stabilizers Sales by Region (2027-2032) & (k units) Table 48. Global Mood Stabilizers Sales Market Share by Region (2027-2032) Table 49. Global Mood Stabilizers Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Mood Stabilizers Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Mood Stabilizers Sales Value Share by Region (2021-2026) Table 52. Global Mood Stabilizers Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Mood Stabilizers Sales Value Share by Region (2027-2032) Table 54. Global Mood Stabilizers Market Average Price (US$/unit) by Region (2021-2026) Table 55. Global Mood Stabilizers Market Average Price (US$/unit) by Region (2027-2032) Table 56. Global Mood Stabilizers Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 57. Global Mood Stabilizers Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Mood Stabilizers Sales by Country (2021-2026) & (k units) Table 59. Global Mood Stabilizers Sales Market Share by Country (2021-2026) Table 60. Global Mood Stabilizers Sales by Country (2027-2032) & (k units) Table 61. Global Mood Stabilizers Sales Market Share by Country (2027-2032) Table 62. Global Mood Stabilizers Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Mood Stabilizers Sales Value Market Share by Country (2021-2026) Table 64. Global Mood Stabilizers Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Mood Stabilizers Sales Value Market Share by Country (2027-2032) Table 66. Pfizer Company Information Table 67. Pfizer Business Overview Table 68. Pfizer Mood Stabilizers Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 69. Pfizer Mood Stabilizers Product Portfolio Table 70. Pfizer Recent Development Table 71. GlaxoSmithKline Company Information Table 72. GlaxoSmithKline Business Overview Table 73. GlaxoSmithKline Mood Stabilizers Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. GlaxoSmithKline Mood Stabilizers Product Portfolio Table 75. GlaxoSmithKline Recent Development Table 76. Otsuka Pharmaceutical Company Information Table 77. Otsuka Pharmaceutical Business Overview Table 78. Otsuka Pharmaceutical Mood Stabilizers Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Otsuka Pharmaceutical Mood Stabilizers Product Portfolio Table 80. Otsuka Pharmaceutical Recent Development Table 81. Bristol-Myers Squibb Company Information Table 82. Bristol-Myers Squibb Business Overview Table 83. Bristol-Myers Squibb Mood Stabilizers Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Bristol-Myers Squibb Mood Stabilizers Product Portfolio Table 85. Bristol-Myers Squibb Recent Development Table 86. Key Raw Materials Table 87. Raw Materials Key Suppliers Table 88. Mood Stabilizers Distributors List Table 89. Mood Stabilizers Customers List Table 90. Research Programs/Design for This Report Table 91. Authors List of This Report Table 92. Secondary Sources Table 93. Primary Sources List of Figures Figure 1. Mood Stabilizers Product Image Figure 2. Global Mood Stabilizers Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Mood Stabilizers Sales Value (2021-2032) & (US$ Million) Figure 4. Global Mood Stabilizers Sales (2021-2032) & (k units) Figure 5. Global Mood Stabilizers Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Mood Stabilizers Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Asenapine Image Figure 10. Valproate Image Figure 11. Carbamazepine Image Figure 12. Lamotrigine Image Figure 13. Global Mood Stabilizers Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Mood Stabilizers Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Mood Stabilizers Sales Volume Share by Type (2021-2032) Figure 16. Global Mood Stabilizers Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Mood Stabilizers Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Mood Stabilizers Sales Value Share by Type (2021-2032) Figure 19. Hospital Pharmacies Image Figure 20. Drug Stores Image Figure 21. Others Image Figure 22. Global Mood Stabilizers Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Mood Stabilizers Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Mood Stabilizers Sales Volume Share by Application (2021-2032) Figure 25. Global Mood Stabilizers Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Mood Stabilizers Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Mood Stabilizers Sales Value Share by Application (2021-2032) Figure 28. Global Mood Stabilizers Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 29. Global Mood Stabilizers Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Mood Stabilizers Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Mood Stabilizers Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Mood Stabilizers Sales Value (2021-2032) & (US$ Million) Figure 33. North America Mood Stabilizers Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Mood Stabilizers Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Mood Stabilizers Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Mood Stabilizers Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Mood Stabilizers Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Mood Stabilizers Sales Value (2021-2032) & (US$ Million) Figure 39. South America Mood Stabilizers Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Mood Stabilizers Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Mood Stabilizers Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Mood Stabilizers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Mood Stabilizers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Mood Stabilizers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Mood Stabilizers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Mood Stabilizers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Mood Stabilizers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Mood Stabilizers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Mood Stabilizers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Mood Stabilizers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Mood Stabilizers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Mood Stabilizers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Mood Stabilizers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Mood Stabilizers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Mood Stabilizers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Mood Stabilizers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Mood Stabilizers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Mood Stabilizers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Mood Stabilizers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Mood Stabilizers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Mood Stabilizers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Mood Stabilizers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Mood Stabilizers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Mood Stabilizers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Mood Stabilizers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Mood Stabilizers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Mood Stabilizers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Mood Stabilizers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Mood Stabilizers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Mood Stabilizers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Mood Stabilizers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Mood Stabilizers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Mood Stabilizers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Mood Stabilizers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Mood Stabilizers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Mood Stabilizers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Mood Stabilizers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Mood Stabilizers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Mood Stabilizers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Mood Stabilizers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Mood Stabilizers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Mood Stabilizers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Mood Stabilizers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Mood Stabilizers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Mood Stabilizers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Mood Stabilizers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Mood Stabilizers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Mood Stabilizers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Mood Stabilizers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Mood Stabilizers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Mood Stabilizers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Mood Stabilizers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Mood Stabilizers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Mood Stabilizers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Mood Stabilizers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Mood Stabilizers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Mood Stabilizers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Mood Stabilizers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Mood Stabilizers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Mood Stabilizers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Mood Stabilizers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Mood Stabilizers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Mood Stabilizers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Mood Stabilizers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Mood Stabilizers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Mood Stabilizers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Mood Stabilizers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Mood Stabilizers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Mood Stabilizers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Mood Stabilizers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Mood Stabilizers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Mood Stabilizers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Mood Stabilizers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Mood Stabilizers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Mood Stabilizers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Mood Stabilizers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Mood Stabilizers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Mood Stabilizers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Mood Stabilizers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Mood Stabilizers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Mood Stabilizers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Mood Stabilizers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Mood Stabilizers Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Mood Stabilizers Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Mood Stabilizers Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Mood Stabilizers Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Mood Stabilizers Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Asenapine
  • Valproate
  • Carbamazepine
  • Lamotrigine
Applications
  • Hospital Pharmacies
  • Drug Stores
  • Others
Companies covered
  • Pfizer
  • GlaxoSmithKline
  • Otsuka Pharmaceutical
  • Bristol-Myers Squibb

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Mood Stabilizers Sales Value (2021-2032)
  4. 1.2.2 Global Mood Stabilizers Sales Volume (2021-2032)
  5. 1.2.3 Global Mood Stabilizers Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Mood Stabilizers Market Dynamics
  1. 2.1 Mood Stabilizers Industry Trends
  2. 2.2 Mood Stabilizers Industry Drivers
  3. 2.3 Mood Stabilizers Industry Opportunities and Challenges
  4. 2.4 Mood Stabilizers Industry Restraints
3 Mood Stabilizers Market by Company
  1. 3.1 Global Mood Stabilizers Company Revenue Ranking in 2025
  2. 3.2 Global Mood Stabilizers Revenue by Company (2021-2026)
  3. 3.3 Global Mood Stabilizers Sales Volume by Company (2021-2026)
  4. 3.4 Global Mood Stabilizers Average Price by Company (2021-2026)
  5. 3.5 Global Mood Stabilizers Company Ranking (2024-2026)
  6. 3.6 Global Mood Stabilizers Company Manufacturing Base and Headquarters
  7. 3.7 Global Mood Stabilizers Company Product Type and Application
  8. 3.8 Global Mood Stabilizers Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Mood Stabilizers Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Mood Stabilizers Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Mood Stabilizers Market by Type
  1. 4.1 Mood Stabilizers Type Introduction
  2. 4.1.1 Asenapine
  3. 4.1.2 Valproate
  4. 4.1.3 Carbamazepine
  5. 4.1.4 Lamotrigine
  6. 4.2 Global Mood Stabilizers Sales Volume by Type
  7. 4.2.1 Global Mood Stabilizers Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Mood Stabilizers Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Mood Stabilizers Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Mood Stabilizers Sales Value by Type
  11. 4.3.1 Global Mood Stabilizers Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Mood Stabilizers Sales Value by Type (2021-2032)
  13. 4.3.3 Global Mood Stabilizers Sales Value Share by Type (2021-2032)
5 Mood Stabilizers Market by Application
  1. 5.1 Mood Stabilizers Application Introduction
  2. 5.1.1 Hospital Pharmacies
  3. 5.1.2 Drug Stores
  4. 5.1.3 Others
  5. 5.2 Global Mood Stabilizers Sales Volume by Application
  6. 5.2.1 Global Mood Stabilizers Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Mood Stabilizers Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Mood Stabilizers Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Mood Stabilizers Sales Value by Application
  10. 5.3.1 Global Mood Stabilizers Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Mood Stabilizers Sales Value by Application (2021-2032)
  12. 5.3.3 Global Mood Stabilizers Sales Value Share by Application (2021-2032)
6 Mood Stabilizers Regional Sales and Value Analysis
  1. 6.1 Global Mood Stabilizers Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Mood Stabilizers Sales by Region (2021-2032)
  3. 6.2.1 Global Mood Stabilizers Sales by Region: 2021-2026
  4. 6.2.2 Global Mood Stabilizers Sales by Region (2027-2032)
  5. 6.3 Global Mood Stabilizers Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Mood Stabilizers Sales Value by Region (2021-2032)
  7. 6.4.1 Global Mood Stabilizers Sales Value by Region: 2021-2026
  8. 6.4.2 Global Mood Stabilizers Sales Value by Region (2027-2032)
  9. 6.5 Global Mood Stabilizers Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Mood Stabilizers Sales Value (2021-2032)
  12. 6.6.2 North America Mood Stabilizers Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Mood Stabilizers Sales Value (2021-2032)
  15. 6.7.2 Europe Mood Stabilizers Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Mood Stabilizers Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Mood Stabilizers Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Mood Stabilizers Sales Value (2021-2032)
  21. 6.9.2 South America Mood Stabilizers Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Mood Stabilizers Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Mood Stabilizers Sales Value Share by Country, 2025 VS 2032
7 Mood Stabilizers Country-level Sales and Value Analysis
  1. 7.1 Global Mood Stabilizers Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Mood Stabilizers Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Mood Stabilizers Sales by Country (2021-2032)
  4. 7.3.1 Global Mood Stabilizers Sales by Country (2021-2026)
  5. 7.3.2 Global Mood Stabilizers Sales by Country (2027-2032)
  6. 7.4 Global Mood Stabilizers Sales Value by Country (2021-2032)
  7. 7.4.1 Global Mood Stabilizers Sales Value by Country (2021-2026)
  8. 7.4.2 Global Mood Stabilizers Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Mood Stabilizers Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Mood Stabilizers Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Mood Stabilizers Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Mood Stabilizers Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Mood Stabilizers Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Mood Stabilizers Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Mood Stabilizers Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Mood Stabilizers Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Mood Stabilizers Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Mood Stabilizers Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Mood Stabilizers Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Mood Stabilizers Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Mood Stabilizers Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Mood Stabilizers Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Mood Stabilizers Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Mood Stabilizers Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Mood Stabilizers Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Mood Stabilizers Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Mood Stabilizers Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Mood Stabilizers Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Mood Stabilizers Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Mood Stabilizers Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Mood Stabilizers Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Mood Stabilizers Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Mood Stabilizers Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Mood Stabilizers Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Mood Stabilizers Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Mood Stabilizers Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Mood Stabilizers Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Mood Stabilizers Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Mood Stabilizers Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Mood Stabilizers Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Mood Stabilizers Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Mood Stabilizers Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Mood Stabilizers Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Mood Stabilizers Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Mood Stabilizers Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Mood Stabilizers Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Mood Stabilizers Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Mood Stabilizers Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Mood Stabilizers Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Mood Stabilizers Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Mood Stabilizers Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Mood Stabilizers Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Mood Stabilizers Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Mood Stabilizers Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Mood Stabilizers Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Mood Stabilizers Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Mood Stabilizers Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Mood Stabilizers Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Mood Stabilizers Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Mood Stabilizers Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Mood Stabilizers Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Mood Stabilizers Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Mood Stabilizers Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Mood Stabilizers Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Mood Stabilizers Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Mood Stabilizers Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Mood Stabilizers Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Mood Stabilizers Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Mood Stabilizers Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Mood Stabilizers Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Mood Stabilizers Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Mood Stabilizers Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Mood Stabilizers Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Mood Stabilizers Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Mood Stabilizers Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Mood Stabilizers Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Mood Stabilizers Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Mood Stabilizers Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Mood Stabilizers Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Mood Stabilizers Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Mood Stabilizers Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Mood Stabilizers Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Mood Stabilizers Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Mood Stabilizers Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Mood Stabilizers Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Mood Stabilizers Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Mood Stabilizers Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Mood Stabilizers Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Mood Stabilizers Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Mood Stabilizers Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Mood Stabilizers Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Mood Stabilizers Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Pfizer
  2. 8.1.1 Pfizer Company Information
  3. 8.1.2 Pfizer Business Overview
  4. 8.1.3 Pfizer Mood Stabilizers Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Pfizer Mood Stabilizers Product Portfolio
  6. 8.1.5 Pfizer Recent Developments
  7. 8.2 GlaxoSmithKline
  8. 8.2.1 GlaxoSmithKline Company Information
  9. 8.2.2 GlaxoSmithKline Business Overview
  10. 8.2.3 GlaxoSmithKline Mood Stabilizers Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 GlaxoSmithKline Mood Stabilizers Product Portfolio
  12. 8.2.5 GlaxoSmithKline Recent Developments
  13. 8.3 Otsuka Pharmaceutical
  14. 8.3.1 Otsuka Pharmaceutical Company Information
  15. 8.3.2 Otsuka Pharmaceutical Business Overview
  16. 8.3.3 Otsuka Pharmaceutical Mood Stabilizers Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Otsuka Pharmaceutical Mood Stabilizers Product Portfolio
  18. 8.3.5 Otsuka Pharmaceutical Recent Developments
  19. 8.4 Bristol-Myers Squibb
  20. 8.4.1 Bristol-Myers Squibb Company Information
  21. 8.4.2 Bristol-Myers Squibb Business Overview
  22. 8.4.3 Bristol-Myers Squibb Mood Stabilizers Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Bristol-Myers Squibb Mood Stabilizers Product Portfolio
  24. 8.4.5 Bristol-Myers Squibb Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Mood Stabilizers Value Chain Analysis
  2. 9.1.1 Mood Stabilizers Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Mood Stabilizers Sales Mode & Process
  6. 9.2 Mood Stabilizers Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Mood Stabilizers Distributors
  9. 9.2.3 Mood Stabilizers Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst